 |
|
|
| Financial Report |
 |
 |
| Labor Report |
| |
|
|
 |
|
 |
 |
 |
 |
 |
| Amgen Incorporated |
 |
|
ICON Press Release
|
AVAILABLE NOW! LABOR PRODUCTIVITY BENCHMARKS AND VERTICAL GAP ANALYSIS ON Amgen Incorporated San Diego - – Published today by ICON Group International, Ltd. Two of the most comprehensive studies to date on labor productivity and vertical gap analysis benchmarks for Amgen Incorporated (NAS: AMGN). The methodologist for this unique study is Philip Parker, Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). According to Professor Parker, “With the globalization of markets, greater foreign competition, and the reduction of barriers to entry, it becomes all the more important to benchmark a company’s financial indicators on a worldwide basis. World stock markets have recently witnessed a return to fundamental financial analysis. ” The goal of the reports is to assist consultants, financial managers, strategic planners, and corporate officers in gauging certain indicators of Amgen Incorporated’s financial and human resource structure. The report has benchmarked Amgen Incorporated against competing firms in the Drugs industry worldwide—going beyond traditional methods of company benchmarking. The results are two specialized reports: (1) global financial benchmarks using common-size statement ratios (vertical analysis), and (2) labor productivity and utilization measures collected across borders.
Two reports, financial ratios and labor productivity ratios, are available for Amgen Incorporated. Each report reveals productivity and industry ranks for Amgen Incorporated in the Drugs industry. Reports for the following and many other Drugs companies are available now:
The vertical analysis deals with questions like: How has Amgen Incorporated’s asset structure varied compared to global benchmarks for the Drugs industry? Does it generally hold more cash and other short-term assets, or does it tend to concentrate its assets in physical plant and equipment? On the liability side, does Amgen Incorporated typically have a higher percent of payables compared to the benchmarks, or does it hold a higher concentration of long-term debt? Does Amgen Incorporated have a relatively higher cost of goods sold, operating costs, or income taxes compared to global benchmarks? Have Amgen Incorporated’s returns on equity been higher or its profit margins greater? While the labor productivity analysis answers the following: What has been the ratio of short-term and long-term assets to employee? What are typical capital-labor ratios? What are the average sales and net profits per employee compared to global benchmarks? Professor Parker notes, "We are intrigued by the wide variations in basic financial and productivity measures between Amgen Incorporated and other Drugs companies. The Earnings Before Interest And Taxes (EBIT), for example, varied from -6 to 48.39. We see this type of variation in the hundreds of ratios that we estimate.”
Most vertical analyses merely focus on benchmarking against domestic ratios, often published by government agencies or commercial sources. In contrast, the report calculates thousands of industry norms by looking at firms at the global level, pooling statistics on tens of thousands of companies across over 40 countries, and applying a seven-stage methodology: (1) identification of industry classifications, (2) firm-level data collection and aggregation, (3) standardization of raw statistics, (4) filtering outliers, (5) calculation of global norms, (6) projection of deviations and gaps, and (7) projection of ranks and percentiles. For each part of the financial statement, the larger structural differences and gaps between Amgen Incorporated. and the global benchmarks are provided with summary tables of ranks and percentiles. Previously available only through booksellers such as Hoovers, Amazon.com, and Barnes and Noble, two studies are now available direct from the publisher at a 50% discount off the cover price. This special offer includes International Competitive Benchmarks and Financial Gap Analysis and Labor Productivity Benchmarks and International Gap Analysis at US$ $420 ($210) each. E-mail
FINANCIAL BENCHMARKS
LABOR BENCHMARKS
About ICON Group Ltd.
Important Disclaimer: This report was not prepared on behalf of or for Amgen Incorporated. Please refer to alternative information sources on Amgen Incorporated for the following: company financials (quarterly reports, annual report, forecasting, analyst reports, stock filing history, investor reports and relations, SEC or EDGAR documents, 10K, 10Q, articles, news press releases, projections, predictions, forecasts), products or services (warranty, guarantee, credit, equipment, accessory or accessories, service, repair or repairs, rebates or rebate policy, product discount or discounts, part or parts supply, price or prices, book value or valuation, logo design), personnel information (jobs, careers, career training, job placement, employment, human resources department, employee compensation or salaries, salary policy, benefit policies for employees, university benefits, credit union benefits), finding corporation location or contact information (map, company mail, mailing street address, corporate investor contacts, website web site, email search, e-mail addresses, regional offices, dealers list, distributors listing, stores directory, outlets, contact names, CFO, CEO, COO, CIO, CTO, HR, office manager, people, welcome, conference, etc.), geographic or production locations (e.g. USA, UK, Canada, Europe, Asia, Africa, China), legal structure or business activity (corporation, incorporated, company, partner, partnership, partnerships, alliances, limited liability, corp., inc, ltd, co, lawsuit or lawsuits), management plans (marketing strategy or strategic intelligence). ICON reports do not comment on any of the above. | ||
for more information.